Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,293 public trials 504 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

NCT00937560

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Hospital Amaral Carvalho Jaú, São Paulo, Brazil
  • Hospital das Clinicas - FMUSP, Oncologia São Paulo, Brazil
  • Centre Hospitalier Henri Duffaut; Hematologie Avignon, France
  • Clinique Tivoli; Sce Radiotherapie Bordeaux, France
View all 55 locations
View Trial Details
Completed

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

NCT00857545

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +38 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 46 locations
View Trial Details
Completed

Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01039207

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Florida Hospital Orlando Orlando, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 28 locations
View Trial Details

Related conditions